Pierre F. Dodion

Pierre F. Dodion discloses dealings in Ariad Pharmaceuticals Inc to SEC (Form 4). In total, 40 filings cover trades dated from 4 August 2009 to 22 November 2013.

The open-market side counts 1 purchase for €6,938 alongside 17 sales for €2.5M. Taken together, the sales exceed the purchases by €2.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants and 19 option exercises. In 2013 alone, the filings show no purchases and 4 sales.

The record was last updated on 22 November 2013 with an option exercise in Ariad Pharmaceuticals Inc. The most recent open-market purchase was published on 6 August 2009, 6,304 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.